Surgery Partners Valuation
| SGRY Stock | USD 15.46 0.03 0.19% |
At this time, the company appears to be undervalued. Surgery Partners has a current Real Value of $17.95 per share. The regular price of the company is $15.46. Our model measures the value of Surgery Partners from inspecting the company fundamentals such as Operating Margin of 0.16 %, shares outstanding of 129.34 M, and Return On Equity of 0.0066 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Surgery Partners' valuation include:
Price Book 1.1562 | Enterprise Value | Enterprise Value Ebitda 10.1859 | Price Sales 0.6081 | Forward PE 18.2149 |
Undervalued
Today
Please note that Surgery Partners' price fluctuation is not too volatile at this time. Calculation of the real value of Surgery Partners is based on 3 months time horizon. Increasing Surgery Partners' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Surgery Partners is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgery Stock. However, Surgery Partners' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.46 | Real 17.95 | Target 25.45 | Hype 15.36 |
The intrinsic value of Surgery Partners' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Surgery Partners' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Surgery Partners helps investors to forecast how Surgery stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgery Partners more accurately as focusing exclusively on Surgery Partners' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Surgery Partners' intrinsic value based on its ongoing forecasts of Surgery Partners' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Surgery Partners' closest peers.
Surgery Partners Cash |
|
Surgery Revenue by Product
Surgery Partners Total Value Analysis
Surgery Partners is at this time projected to have valuation of 5.67 B with market capitalization of 2 B, debt of 3.7 B, and cash on hands of 227.4 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Surgery Partners fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.67 B | 2 B | 3.7 B | 227.4 M |
Surgery Partners Investor Information
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.16. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 1.36. The firm had not issued any dividends in recent years. Based on the key indicators related to Surgery Partners' liquidity, profitability, solvency, and operating efficiency, Surgery Partners is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.15 | 0.13 |
|
| |||||
| Total Cash From Operating Activities | 362.4 M | 345.1 M |
|
| |||||
| Operating Income | 210.7 M | 401.1 M |
|
|
Surgery Partners Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Surgery Partners has an asset utilization ratio of 39.47 percent. This suggests that the Company is making $0.39 for each dollar of assets. An increasing asset utilization means that Surgery Partners is more efficient with each dollar of assets it utilizes for everyday operations.Surgery Partners Profitability Analysis
Based on Surgery Partners' profitability indicators, Surgery Partners' profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Surgery Partners' ability to earn profits and add value for shareholders.Net Loss | First Reported 2013-12-31 | Previous Quarter -2.5 M | Current Value -22.7 M | Quarterly Volatility 29 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.31 | 0.28 |
|
| |||||
| Operating Profit Margin | 0.15 | 0.13 |
|
|
For Surgery Partners profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Surgery Partners to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Surgery Partners utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Surgery Partners's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Surgery Partners over time as well as its relative position and ranking within its peers.
Surgery Partners Earnings per Share Projection vs Actual
The next projected EPS of Surgery Partners is estimated to be 0.172075 with future projections ranging from a low of 0.06 to a high of 0.23. Surgery Partners' most recent 12-month trailing earnings per share (EPS TTM) is at -1.36. Please be aware that the consensus of earnings estimates for Surgery Partners is based on EPS before non-recurring items and includes expenses related to employee stock options.Surgery Partners Earnings Estimation Breakdown
The calculation of Surgery Partners' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Surgery Partners is estimated to be 0.172075 with the future projection ranging from a low of 0.06 to a high of 0.23. Please be aware that this consensus of annual earnings estimates for Surgery Partners is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.06 Lowest | Expected EPS | 0.23 Highest |
Surgery Partners Earnings Projection Consensus
Suppose the current estimates of Surgery Partners' value are higher than the current market price of the Surgery Partners stock. In this case, investors may conclude that Surgery Partners is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Surgery Partners' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 12 | 46.46% | 0.0 | 0.172075 | -1.36 |
Surgery Partners Ownership Allocation
The majority of Surgery Partners outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Surgery Partners to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Surgery Partners. Please pay attention to any change in the institutional holdings of Surgery Partners as this could imply that something significant has changed or is about to change at the company.Surgery Partners Profitability Analysis
The company reported the previous year's revenue of 3.11 B. Net Income was 12.5 M with profit before overhead, payroll, taxes, and interest of 786.4 M.About Surgery Partners Valuation
Our relative valuation model uses a comparative analysis of Surgery Partners. We calculate exposure to Surgery Partners's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Surgery Partners's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 857.4 M | 900.3 M | |
| Pretax Profit Margin | 0.05 | 0.03 | |
| Operating Profit Margin | 0.13 | 0.15 | |
| Net Loss | (0.05) | (0.05) | |
| Gross Profit Margin | 0.28 | 0.31 |
Surgery Partners Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 126.1 M | |
| Forward Price Earnings | 18.2149 |
Surgery Partners Current Valuation Indicators
Valuation refers to the process of determining the present value of Surgery Partners and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Surgery we look at many different elements of the entity such as Surgery's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Surgery Partners, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Surgery Partners' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Surgery Partners' worth.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.